FI925849A7 - Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar - Google Patents
Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar Download PDFInfo
- Publication number
- FI925849A7 FI925849A7 FI925849A FI925849A FI925849A7 FI 925849 A7 FI925849 A7 FI 925849A7 FI 925849 A FI925849 A FI 925849A FI 925849 A FI925849 A FI 925849A FI 925849 A7 FI925849 A7 FI 925849A7
- Authority
- FI
- Finland
- Prior art keywords
- thiazolidinfoereningar
- anvaendningar
- therapeutic
- deras framstaellning
- framstaellning och
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34457191 | 1991-12-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI925849A0 FI925849A0 (fi) | 1992-12-23 |
| FI925849A7 true FI925849A7 (fi) | 1993-06-27 |
Family
ID=18370304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI925849A FI925849A7 (fi) | 1991-12-26 | 1992-12-23 | Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0549365B1 (Direct) |
| JP (1) | JP2833949B2 (Direct) |
| CN (1) | CN1032751C (Direct) |
| AT (1) | ATE126221T1 (Direct) |
| AU (1) | AU654223B2 (Direct) |
| CA (1) | CA2086277A1 (Direct) |
| CZ (1) | CZ389792A3 (Direct) |
| DE (1) | DE69204041T2 (Direct) |
| DK (1) | DK0549365T3 (Direct) |
| ES (1) | ES2078671T3 (Direct) |
| FI (1) | FI925849A7 (Direct) |
| GR (1) | GR3017632T3 (Direct) |
| HK (1) | HK196095A (Direct) |
| HU (1) | HU215450B (Direct) |
| IL (1) | IL104238A (Direct) |
| MX (1) | MX9207595A (Direct) |
| NO (1) | NO302471B1 (Direct) |
| NZ (1) | NZ245612A (Direct) |
| RU (1) | RU2095354C1 (Direct) |
| TW (1) | TW211007B (Direct) |
| ZA (1) | ZA9210021B (Direct) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO302519B1 (no) * | 1991-12-26 | 1998-03-16 | Sankyo Co | Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat |
| CA2146701A1 (en) * | 1994-04-11 | 1995-10-12 | Takashi Fujita | Heterocyclic compounds having anti-diabetic activity, their preparation and their use |
| EP0783888A1 (en) * | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis |
| US6331633B1 (en) * | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
| DE19828113A1 (de) * | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
| DE19828114A1 (de) * | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
| DE19926233C1 (de) * | 1999-06-10 | 2000-10-19 | Probiodrug Ges Fuer Arzneim | Verfahren zur Herstellung von Thiazolidin |
| US6620830B2 (en) | 2000-04-21 | 2003-09-16 | Pfizer, Inc. | Thyroid receptor ligands |
| ES2248242T3 (es) * | 2000-04-21 | 2006-03-16 | Pfizer Products Inc. | Ligandos de receptores tiroideos. |
| US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| AU2001259130A1 (en) * | 2000-04-24 | 2001-11-07 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| JP2003040877A (ja) * | 2001-07-24 | 2003-02-13 | Sumika Fine Chemicals Co Ltd | ５−［６−（２−フルオロベンジルオキシ）−２−ナフチル］メチル−２，４−チアゾリジンジオンの製造方法及びその精製方法 |
| MX2008011872A (es) | 2006-03-16 | 2009-02-10 | Metabolic Solutions Dev Compan | Analogos de tiazolidinediona para el tratamiento de la hipertension y para disminuir lipidos. |
| MX356584B (es) | 2006-03-16 | 2018-06-05 | Metabolic Solutions Dev Co | Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica. |
| NZ597381A (en) * | 2007-09-14 | 2013-03-28 | Metabolic Solutions Dev Co Llc | Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases |
| US8304441B2 (en) | 2007-09-14 | 2012-11-06 | Metabolic Solutions Development Company, Llc | Thiazolidinedione analogues for the treatment of metabolic diseases |
| HUE038042T2 (hu) | 2009-12-15 | 2018-09-28 | Cirius Therapeutics Inc | PPAR helyettesítõ tiazolidindion sók metabolikus betegségek kezelésére |
| ES2610623T3 (es) * | 2010-04-19 | 2017-04-28 | Octeta Therapeutics, Llc | Nueva síntesis de compuestos de tiazolidindiona |
| US20130281414A1 (en) * | 2010-04-21 | 2013-10-24 | Metabolic Solutions Development Company, Llc | Thiazolidinedione analogues |
| JP5927190B2 (ja) | 2010-08-10 | 2016-06-01 | メタボリック ソリューションズ ディベロップメント カンパニー， エルエルシー | チアゾリジンジオン化合物のための新規合成 |
| CN115433144B (zh) * | 2022-10-09 | 2023-09-19 | 燃点(南京)生物医药科技有限公司 | 一种脂肪酸酯类化合物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
| US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| NO302519B1 (no) * | 1991-12-26 | 1998-03-16 | Sankyo Co | Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat |
-
1992
- 1992-12-22 NO NO924964A patent/NO302471B1/no unknown
- 1992-12-23 FI FI925849A patent/FI925849A7/fi not_active Application Discontinuation
- 1992-12-23 HU HUP9204130A patent/HU215450B/hu not_active IP Right Cessation
- 1992-12-23 NZ NZ245612A patent/NZ245612A/en unknown
- 1992-12-23 ZA ZA9210021A patent/ZA9210021B/xx unknown
- 1992-12-24 CA CA002086277A patent/CA2086277A1/en not_active Abandoned
- 1992-12-24 DE DE69204041T patent/DE69204041T2/de not_active Expired - Fee Related
- 1992-12-24 AU AU30431/92A patent/AU654223B2/en not_active Ceased
- 1992-12-24 AT AT92311813T patent/ATE126221T1/de not_active IP Right Cessation
- 1992-12-24 TW TW081110354A patent/TW211007B/zh active
- 1992-12-24 DK DK92311813.7T patent/DK0549365T3/da active
- 1992-12-24 EP EP92311813A patent/EP0549365B1/en not_active Expired - Lifetime
- 1992-12-24 ES ES92311813T patent/ES2078671T3/es not_active Expired - Lifetime
- 1992-12-25 IL IL10423892A patent/IL104238A/en not_active IP Right Cessation
- 1992-12-25 RU RU9292016231A patent/RU2095354C1/ru active
- 1992-12-25 JP JP4346122A patent/JP2833949B2/ja not_active Expired - Fee Related
- 1992-12-26 CN CN92115234A patent/CN1032751C/zh not_active Expired - Fee Related
- 1992-12-28 CZ CS923897A patent/CZ389792A3/cs unknown
- 1992-12-28 MX MX9207595A patent/MX9207595A/es not_active IP Right Cessation
-
1995
- 1995-10-04 GR GR950402745T patent/GR3017632T3/el unknown
- 1995-12-28 HK HK196095A patent/HK196095A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK196095A (en) | 1996-01-05 |
| HU9204130D0 (en) | 1993-04-28 |
| JPH05239041A (ja) | 1993-09-17 |
| EP0549365B1 (en) | 1995-08-09 |
| NO302471B1 (no) | 1998-03-09 |
| FI925849A0 (fi) | 1992-12-23 |
| DE69204041T2 (de) | 1996-03-28 |
| NO924964L (no) | 1993-06-28 |
| ZA9210021B (en) | 1993-07-02 |
| HU215450B (hu) | 1999-04-28 |
| CA2086277A1 (en) | 1993-06-27 |
| HUT67788A (en) | 1995-04-28 |
| CZ389792A3 (en) | 1994-01-19 |
| GR3017632T3 (en) | 1996-01-31 |
| EP0549365A1 (en) | 1993-06-30 |
| CN1074680A (zh) | 1993-07-28 |
| MX9207595A (es) | 1994-06-30 |
| JP2833949B2 (ja) | 1998-12-09 |
| IL104238A (en) | 1996-10-31 |
| ES2078671T3 (es) | 1995-12-16 |
| TW211007B (Direct) | 1993-08-11 |
| NZ245612A (en) | 1994-06-27 |
| ATE126221T1 (de) | 1995-08-15 |
| AU654223B2 (en) | 1994-10-27 |
| CN1032751C (zh) | 1996-09-11 |
| AU3043192A (en) | 1993-07-01 |
| NO924964D0 (no) | 1992-12-22 |
| DE69204041D1 (de) | 1995-09-14 |
| RU2095354C1 (ru) | 1997-11-10 |
| DK0549365T3 (da) | 1995-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI935795L (fi) | Ctl4a-receptor, fusionsproteiner innehaollande denna och anvaendningar daerav | |
| FI923337L (fi) | Organiska fluorenylmetallfoereningar, framstaellning och anvaendning daerav | |
| FI922977L (fi) | Heterocykliska foereningar, deras framstaellning och anvaendning | |
| FI923366L (fi) | 5-lediga heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel | |
| FI923960L (fi) | 5-ledad heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel | |
| FI921030L (fi) | Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
| FI923691L (fi) | Cykliska iminoderivat, dessa foereningar innehaollande farmaceutiska blandningar och foerfarande foer deras framstaellning | |
| FI924069L (fi) | Terapeutiskt anvaendbara peptider och peptidfragment | |
| FI924687L (fi) | Heterobiarylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
| FI923223A7 (fi) | Alkenylgrupper omfattande siloxankopolymerer, deras framstaellning och anvaendning | |
| FI923775L (fi) | 2-piperazinonfoereningar, deras framstaellning och anvaendning | |
| FI934426L (fi) | Tiazolidindionderivat, framstaellning och anvaendning daerav | |
| FI920749A7 (fi) | 1-bifenylmetylimidazolderivat, deras framstaellning och terapeutiska anvaendning | |
| FI924084L (fi) | Tramadol-n-oxidmaterial, enantiomerer och kompositioner daerav och deras anvaendning | |
| FI923947A7 (fi) | Foerfarande foer pulsbreddsmodulation foer oekad linearitet, minskad kommutationsfoerlust och oekad utspaenning i en vaexelriktare/omriktare | |
| FI925849A7 (fi) | Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar | |
| FI921049L (fi) | Hydrazonderivat, deras framstaellning och anvaendning | |
| FI922983L (fi) | Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa | |
| FI922875L (fi) | Foereningar med reninhaemmande egenskaper, foerfarande foer deras framstaellning och deras anvaendning | |
| FI924869L (fi) | Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa | |
| FI925848A7 (fi) | Tizolidinfoereningar, som innehaoller en kinogrupp, deras framstaellning och terapeutiska anvaendningar | |
| FI925501L (fi) | Imidazolfoereningar, deras framstaellning och anvaendning | |
| FI922390L (fi) | Initiatorsuspensioner, deras framstaellning och anvaendning | |
| FI924617A7 (fi) | Anordning foer viktinstaellning av instaellning av sittyta och ryggstoed istolar, saerskilt byrosvaengstolar | |
| FI922982L (fi) | 2-aminopyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |